載入中
NASDAQHealthcareMedical - Healthcare Information Services
最新資料
US$0.9814
+US$0.0051 · +0.52%
Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from the early stages of product development to strategic market entry planning and effective sales and marketing execution. Its sophisticated platform incorporates sixteen distinct intelligence modules. These modules are designed to support key functional domains such as sales optimization, marketing initiatives, clinical research, new product creation, strategic planning, human capital acquisition, and the oversight of physician networks. Definitive Healthcare caters to a broad spectrum of clients, including biopharmaceutical firms, medical device manufacturers, healthcare information technology companies, and direct healthcare providers. Additionally, its clientele extends to diverse organizations within the wider healthcare ecosystem, such as staffing and commercial real estate companies, financial institutions, and other related entities. Founded in 2011, Definitive Healthcare Corp. is headquartered in Framingham, Massachusetts.
收盤時
US$0.9814
+US$0.0051 · +0.52%
盤後
US$0.9801
−US$0.0013 · -0.13%
10月13日 下午4:07 ET
盤中時間採用ET。市場資料可能有所延遲。
Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from the early stages of product development to strategic market entry planning and effective sales and marketing execution. Its sophisticated platform incorporates sixteen distinct intelligence modules. These modules are designed to support key functional domains such as sales optimization, marketing initiatives, clinical research, new product creation, strategic planning, human capital acquisition, and the oversight of physician networks. Definitive Healthcare caters to a broad spectrum of clients, including biopharmaceutical firms, medical device manufacturers, healthcare information technology companies, and direct healthcare providers. Additionally, its clientele extends to diverse organizations within the wider healthcare ecosystem, such as staffing and commercial real estate companies, financial institutions, and other related entities. Founded in 2011, Definitive Healthcare Corp. is headquartered in Framingham, Massachusetts.
日內區間
目前US$0.9814
52週區間
目前US$0.9814
盤中時間採用ET。市場資料可能有所延遲。
Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from the early stages of product development to strategic market entry planning and effective sales and marketing execution. Its sophisticated platform incorporates sixteen distinct intelligence modules. These modules are designed to support key functional domains such as sales optimization, marketing initiatives, clinical research, new product creation, strategic planning, human capital acquisition, and the oversight of physician networks. Definitive Healthcare caters to a broad spectrum of clients, including biopharmaceutical firms, medical device manufacturers, healthcare information technology companies, and direct healthcare providers. Additionally, its clientele extends to diverse organizations within the wider healthcare ecosystem, such as staffing and commercial real estate companies, financial institutions, and other related entities. Founded in 2011, Definitive Healthcare Corp. is headquartered in Framingham, Massachusetts.
日內區間
目前US$0.9814
52週區間
目前US$0.9814
近期已公布業績
近期已公布業績
第三方分析師預期可能變動，並非 GoAI 建議。
平均目標
US$1.20
上漲空間 22.27%報告持有此股票曝險的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI126.13萬0.00%2.3兆 USD0.03%US$381.32-0.07%
Dimensional - US Small Cap ETFDFAS61.99萬0.00%338.04億 USD0.31%US$78.33+0.20%
Vanguard Extended Market ETFVXF45.38萬0.00%954億 USD0.05%US$232.54-0.42%
U.S. Micro Cap Portfolio ETFDFMC26.83萬0.00%75.44億 USD0.43%US$57.78+0.14%
Dimensional - US Core Equity 2 ETFDFAC19.95萬0.00%885.59億 USD0.21%US$45.35+0.09%
iShares Micro-Cap ETFIWC11.31萬0.01%13.07億 USD0.60%US$179.6-1.13%
WisdomTree U.S. SmallCap FundEES11.24萬0.02%6.81億 USD0.38%US$65.72+0.40%
Invesco RAFI US 1500 Small-Mid ETFPRFZ6.94萬0.00%26.54億 USD0.36%US$52.8279-0.17%Vanguard Morningstar Total Stock Market ETFVTIDimensional - US Small Cap ETFDFASVanguard Extended Market ETFVXFU.S. Micro Cap Portfolio ETFDFMCDimensional - US Core Equity 2 ETFDFACiShares Micro-Cap ETFIWCWisdomTree U.S. SmallCap FundEESInvesco RAFI US 1500 Small-Mid ETFPRFZAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
